Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab

Reliable predictors of benefit from immune checkpoint inhibitors in non-small-cell lung cancer (NSCLC) are still limited. We aimed to evaluate the association between the expression of selected molecules involved in immune response and clinical outcomes in NSCLC patients receiving nivolumab. In our...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Clin Med
Main Authors: Genova, Carlo, Boccardo, Simona, Mora, Marco, Rijavec, Erika, Biello, Federica, Rossi, Giovanni, Tagliamento, Marco, Dal Bello, Maria Giovanna, Coco, Simona, Alama, Angela, Vanni, Irene, Barletta, Giulia, Bianchi, Rita, Maggioni, Claudia, Bruzzi, Paolo, Grossi, Francesco
פורמט: Artigo
שפה:Inglês
יצא לאור: MDPI 2019
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6832616/
https://ncbi.nlm.nih.gov/pubmed/31581482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8101566
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים